These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25070798)

  • 41. Barrett's esophagus: ordering the events that lead to cancer.
    Reid BJ; Barrett MT; Galipeau PC; Sanchez CA; Neshat K; Cowan DS; Levine DS
    Eur J Cancer Prev; 1996 Dec; 5 Suppl 2():57-65. PubMed ID: 9061296
    [No Abstract]   [Full Text] [Related]  

  • 42. Microsatellite instability in squamous cell carcinomas and dysplasias of the esophagus.
    Kagawa Y; Yoshida K; Hirai T; Toge T; Yokozaki H; Yasui W; Tahara E
    Anticancer Res; 2000; 20(1A):213-7. PubMed ID: 10769657
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concordant loss of MTAP and p16/CDKN2A expression in gastroesophageal carcinogenesis: evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implications.
    Powell EL; Leoni LM; Canto MI; Forastiere AA; Iocobuzio-Donahue CA; Wang JS; Maitra A; Montgomery E
    Am J Surg Pathol; 2005 Nov; 29(11):1497-504. PubMed ID: 16224217
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
    Whitson MJ; Falk GW
    Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chromosomal rearrangements in Barrett's esophagus. A premalignant lesion of esophageal adenocarcinoma.
    Garewal HS; Sampliner R; Liu Y; Trent JM
    Cancer Genet Cytogenet; 1989 Oct; 42(2):281-6. PubMed ID: 2790761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between Egr-1 gene expression and apoptosis in esophageal carcinoma and precancerous lesions.
    Wu MY; Liang YR; Wu XY; Zhuang CX
    World J Gastroenterol; 2002 Dec; 8(6):971-5. PubMed ID: 12439908
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Barrett's esophagus: a model of human neoplastic progression.
    Neshat K; Sanchez CA; Galipeau PC; Cowan DS; Ramel S; Levine DS; Reid BJ
    Cold Spring Harb Symp Quant Biol; 1994; 59():577-83. PubMed ID: 7587115
    [No Abstract]   [Full Text] [Related]  

  • 48. Vitamin D receptor is highly expressed in precancerous lesions and esophageal adenocarcinoma with significant sex difference.
    Zhou Z; Xia Y; Bandla S; Zakharov V; Wu S; Peters J; Godfrey TE; Sun J
    Hum Pathol; 2014 Aug; 45(8):1744-51. PubMed ID: 24951052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Evolving Genomic Landscape of Barrett's Esophagus and Esophageal Adenocarcinoma.
    Contino G; Vaughan TL; Whiteman D; Fitzgerald RC
    Gastroenterology; 2017 Sep; 153(3):657-673.e1. PubMed ID: 28716721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Base transitions at CpG dinucleotides in the p53 gene are common in esophageal adenocarcinoma.
    Gleeson CM; Sloan JM; McGuigan JA; Ritchie AJ; Russell SE
    Cancer Res; 1995 Aug; 55(15):3406-11. PubMed ID: 7614480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Analysis of p53 mutational spectra of esophageal squamous cell carcinomas from Linzhou, comparison with esophageal and other cancers from other areas].
    Wang LD; Liu B; Zheng S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Mar; 24(3):202-5. PubMed ID: 12816712
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long Noncoding RNAs in the Pathogenesis of Barrett's Esophagus and Esophageal Carcinoma.
    Abraham JM; Meltzer SJ
    Gastroenterology; 2017 Jul; 153(1):27-34. PubMed ID: 28528706
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of gene expression in precancerous rat esophagus by dietary zinc deficit and replenishment.
    Liu CG; Zhang L; Jiang Y; Chatterjee D; Croce CM; Huebner K; Fong LY
    Cancer Res; 2005 Sep; 65(17):7790-9. PubMed ID: 16140947
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ornithine decarboxylase inhibition downregulates multiple pathways involved in the formation of precancerous lesions of esophageal squamous cell cancer.
    Xie Y; Dong CD; Wu Q; Jiang Y; Yao K; Zhang J; Zhao S; Ren Y; Yuan Q; Chen X; Liu Z; Zhao J; Liu K
    Mol Carcinog; 2020 Feb; 59(2):215-226. PubMed ID: 31793679
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study.
    Thrift AP; Shaheen NJ; Gammon MD; Bernstein L; Reid BJ; Onstad L; Risch HA; Liu G; Bird NC; Wu AH; Corley DA; Romero Y; Chanock SJ; Chow WH; Casson AG; Levine DM; Zhang R; Ek WE; MacGregor S; Ye W; Hardie LJ; Vaughan TL; Whiteman DC
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25269698
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular precursor lesions in oesophageal cancer.
    Montesano R; Hainaut P
    Cancer Surv; 1998; 32():53-68. PubMed ID: 10489623
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of Mutations in Barrett's Esophagus Before Progression to High-Grade Dysplasia or Adenocarcinoma.
    Stachler MD; Camarda ND; Deitrick C; Kim A; Agoston AT; Odze RD; Hornick JL; Nag A; Thorner AR; Ducar M; Noffsinger A; Lash RH; Redston M; Carter SL; Davison JM; Bass AJ
    Gastroenterology; 2018 Jul; 155(1):156-167. PubMed ID: 29608884
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Barrett-associated variants at GDF7 and TBX5 also increase esophageal adenocarcinoma risk.
    Becker J; May A; Gerges C; Anders M; Schmidt C; Veits L; Noder T; Mayershofer R; Kreuser N; Manner H; Venerito M; Hofer JH; Lyros O; Ahlbrand CJ; Arras M; Hofer S; Heinrichs SK; Weise K; Hess T; Böhmer AC; Kosiol N; Kiesslich R; Izbicki JR; Hölscher AH; Bollschweiler E; Malfertheiner P; Lang H; Moehler M; Lorenz D; Ott K; Schmidt T; Nöthen MM; Hackelsberger A; Schumacher B; Pech O; Vashist Y; Vieth M; Weismüller J; Knapp M; Neuhaus H; Rösch T; Ell C; Gockel I; Schumacher J
    Cancer Med; 2016 May; 5(5):888-91. PubMed ID: 26783083
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
    Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
    Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic mechanisms in esophageal carcinogenesis: frequent deletion of 3p and 17p in premalignant lesions.
    Shimada M; Yanagisawa A; Kato Y; Inoue M; Shiozaki H; Monden M; Nakamura Y
    Genes Chromosomes Cancer; 1996 Mar; 15(3):165-9. PubMed ID: 8721680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.